Microvesicles from platelets: Novel drivers of vascular inflammation

Thrombosis and Haemostasis

Volumn 114, Issue 2, 2015, Pages 228-236

  Vajen, Tanja ^a   Mause, Sebastian F ^b   Koenen, Rory R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Atherosclerosis; Microparticle; Microvesicle; Platelet; Vascular inflammation

Indexed keywords

BETA3 INTEGRIN; BIOLOGICAL MARKER; CD40 LIGAND; CD63 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; CXCL1 CHEMOKINE; FRACTALKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 5; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; RANTES; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN; CHEMOKINE; FIBRINOGEN RECEPTOR; IMMUNOGLOBULIN; MESSENGER RNA;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL INTERACTION; CELLS BY BODY ANATOMY; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INFLAMMATION; INFLAMMATORY INFILTRATE; MEMBRANE MICROPARTICLE; MONOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; VASCULITIS; ANIMAL; BLOOD; BONE MARROW CELL; CARDIOVASCULAR DISEASE; CELL SEPARATION; CENTRIFUGATION; DISEASE COURSE; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MITOCHONDRION; MOUSE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RABBIT; THROMBOCYTE; THROMBOCYTE ACTIVATION; ULTRASTRUCTURE;

ANIMALS; ATHEROSCLEROSIS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CELL COMMUNICATION; CELL SEPARATION; CELL-DERIVED MICROPARTICLES; CENTRIFUGATION; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; DISEASE PROGRESSION; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULINS; LYMPHOCYTES; MICE; MITOCHONDRIA; MYELOID CELLS; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RABBITS; RNA, MESSENGER; VASCULITIS;

EID: 84938306043     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-11-0962     Document Type: Article

References (124)

1. Mause SF, et al. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005; 25: 1512-1518.
2. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107: 1047-1057.
3. Thery C, et al. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-593.
4. Rondina MT, et al. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013; 112: 1506-1519.
5. Andonegui G, et al. Platelets express functional Toll-like receptor-4. Blood 2005; 106: 2417-2423.
6. Clark SR, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13: 463-469.
7. Wong CH, et al. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol 2013; 14: 785-792.
8. Gawaz M, et al. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-3384.
9. Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res 2005; 96: 612-616.
10. Langer HF, et al. Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res 2012; 110: 1202-1210.
11. Henn V, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-594.
12. Lievens D, et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010; 116: 4317-4327.
13. Lindemann S, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154: 485-490.
14. Gawaz M, et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 2000; 148: 75-85.
15. Huo Y, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-67.
16. Koenen RR, et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009; 15: 97-103.
17. Grommes J, et al. Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med 2012; 185: 628-636.
18. Weyrich AS, et al. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 1995; 95: 2297-2303.
19. Theilmeier G, et al. Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress. Blood 1999; 94: 2725-2734.
20. da Costa Martins P, et al. Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation. Arterioscler Thromb Vasc Biol 2004; 24: 193-199.
21. Postea O, et al. Contribution of platelet CX(3)CR1 to platelet-monocyte complex formation and vascular recruitment during hyperlipidemia. Arterioscler Thromb Vasc Biol 2012; 32: 1186-1193.
22. Hu H, et al. Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus. Thromb Haemost 2010; 104: 1184-1192.
23. Spectre G, et al. Platelets selectively enhance lymphocyte adhesion on subendothelial matrix under arterial flow conditions. Thromb Haemost 2012; 108: 328-337.
24. Naik MU, et al. JAM-A protects from thrombosis by suppressing integrin alphaIIbbeta3- dependent outside-in signaling in platelets. Blood 2012; 119: 3352-3360.
25. Karshovska E, et al. Hyperreactivity of junctional adhesion molecule a-deficient platelets accelerates atherosclerosis in hyperlipidemic mice. Circ Res 2015; 116: 587-599.
26. Liu F, et al. Mitochondrially mediated integrin alphaIIbbeta3 protein inactivation limits thrombus growth. J Biol Chem 2013; 288: 30672-30681.
27. Jobe SM, et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 2008; 111: 1257-1265.
28. Zhang Q, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104-107.
29. Boudreau LH, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 2014; 124: 2173-2183.
30. Morel O, et al. Mechanisms of microparticle generation: on the trail of the mitochondrion! Semin Thromb Hemost 2010; 36: 833-844.
31. Gemmell CH, et al. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. J Biol Chem 1993; 268: 14586-14589.
32. Sims PJ, et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-17057.
33. Yano Y, et al. The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane. Thromb Res 1993; 71: 385-396.
34. Pasquet JM, et al. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem 1996; 239: 647-654.
35. Yano Y, et al. The role of protein phosphorylation and cytoskeletal reorganisation in microparticle formation from the platelet plasma membrane. Biochem J 1994; 299: 303-308.
36. Heijnen HF, et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999; 94: 3791-3799.
37. Kile BT. The role of apoptosis in megakaryocytes and platelets. Br J Haematol 2014; 165: 217-226.
38. Cauwenberghs S, et al. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilisation of actin cytoskeleton. FEBS Lett 2006; 580: 5313-5320.
39. Vasina EM, et al. Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release. Am J Blood Res 2013; 3: 107-123.
40. Montoro-Garcia S, et al. Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. Br J Haematol 2014; 166: 571-580.
41. Aatonen MT, Ohman T, Nyman TA, et al. Isolation and characterisation of platelet- derived extracellular vesicles. J Extracell Vesicles 2014; Epub ahead of print.
42. Hergenreider E, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012; 14: 249-256.
43. Leroyer AS, et al. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularisation. J Am Coll Cardiol 2008; 52: 1302-1311.
44. Loyer X, et al. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014; 114: 345-353.
45. Rand ML, et al. Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost 2006; 4: 1621-1623.
46. Rank A, et al. Clearance of platelet microparticles in vivo. Platelets 2011; 22: 111-116.
47. Dasgupta SK, Abdel-Monem H, Niravath P, et al. Lactadherin and clearance of platelet-derived microvesicles. Blood 2009; 113: 1332-1339.
48. Dasgupta SK, et al. Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation 2012; 125: 1664-1672.
49. Yuana Y, et al. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011; 105: 396-408.
50. Dey-Hazra E, et al. Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing. Vasc Health Risk Manag 2010; 6: 1125-1133.
51. Shantsila E, et al. Circulating microparticles: challenges and perspectives of flow cytometric assessment. Thromb Haemost 2014; 111: 1009-1014.
52. Jy W, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-1851.
53. Ayers L, et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011; 127: 370-377.
54. van Ierssel SH, et al. Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. Thromb Res 2010; 125: 332-339.
55. Witwer KW, et al. Standardisation of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013; Epub ahead of print.
56. Gyorgy B, et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 2011; 117: e39-48.
57. Mobarrez F, et al. A multicolor flow cytometric assay for measurement of platelet- derived microparticles. Thromb Res 2010; 125: e110-116.
58. Berckmans RJ, et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639-646.
59. Chandler WL. Microparticle counts in platelet-rich and platelet-free plasma, effect of centrifugation and sample-processing protocols. Blood Coagul Fibrinolysis 2013; 24: 125-132.
60. Qiao JL, et al. Proteolysis of platelet receptors in humans and other species. Biol Chem 2010; 391: 893-900.
61. Lacroix R, et al. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost 2010; 36: 807-818.
62. van der Vlist EJ, et al. Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry. Nat Protoc 2012; 7: 1311-1326.
63. Lacroix R, et al. Standardisation of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010; 8: 2571-2574.
64. Thery C, et al. Isolation and characterisation of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; Chapter 3: Unit 3 22.
65. Vogel R, et al. Quantitative sizing of nano/microparticles with a tunable elastomeric pore sensor. Anal Chem 2011; 83: 3499-3506.
66. Dragovic RA, et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomed 2011; 7: 780-788.
67. Bell NC, et al. Emerging techniques for submicrometer particle sizing applied to Stober silica. Langmuir 2012; 28: 10860-10872.
68. Varga Z, et al. Towards traceable size determination of extracellular vesicles. J Extracell Vesicles 2014; Epub ahead of print.
69. Harapin J, et al. Structural analysis of supramolecular assemblies by cryo-electron tomography. Structure 2013; 21: 1522-1530.
70. Yuana Y, et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost 2010; 8: 315-323.
71. Ueba T, et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost 2008; 100: 280-285.
72. Nielsen MH, et al. A flow cytometric method for characterisation of circulating cell-derived microparticles in plasma. J Extracell Vesicles 2014; Epub ahead of print.
73. Amabile N, et al. Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 2010; 36: 907-916.
74. Tan KT, et al. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Ann Med 2005; 37: 61-66.
75. Namba M, et al. Circulating platelet-derived microparticles are associated with atherothrombotic events: a marker for vulnerable blood. Arterioscler Thromb Vasc Biol 2007; 27: 255-256.
76. van der Zee PM, et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006; 52: 657-664.
77. Cohen Z, et al. Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation. Thromb Res 2002; 107: 217-221.
78. Trzepizur W, et al. Microparticles and vascular dysfunction in obstructive sleep apnoea. Eur Respir J 2014; 44: 207-216.
79. Sabatier F, et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002; 51: 2840-2845.
80. Preston RA, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41: 211-217.
81. Murakami T, et al. Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb Res 2007; 119: 45-53.
82. Helal O, et al. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. Nutr Metab Cardiovasc Dis 2011; 21: 665-671.
83. Suades R, et al. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost 2013; 110: 366-377.
84. Suades R, et al. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients. Thromb Haemost 2014; 111: 111-121.
85. Mobarrez F, et al. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost 2011; 106: 344-352.
86. Jayachandran M, et al. Characterisation of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol 2008; 295: H931-H938.
87. Mause SF. Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis. Thromb Haemost 2013; 109: 5-6.
88. Merten M, et al. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999; 99: 2577-2582.
89. Suades R, et al. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost 2012; 108: 1208-1219.
90. Agouni A, et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008; 173: 1210-1219.
91. Agouni A, et al. Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice. PLoS one 2011; 6: e27809.
92. Hansson GK, et al. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169-175.
93. Sadallah S, et al. Ectosomes released by platelets induce differentiation of CD4+T cells into T regulatory cells. Thromb Haemost 2014; 112: 1219-1229.
94. Weber A, et al. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res 2000; 98: 461-466.
95. Butoi ED, et al. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules. Biochim Biophys Acta 2011; 1813: 2026-2035.
96. Boilard E, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327: 580-583.
97. Jancar S, Sanchez Crespo M. Immune complex-mediated tissue injury: a multistep paradigm. Trends Immunol 2005; 26: 48-55.
98. Mayadas TN, et al. Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Circulation 2009; 120: 2012-2024.
99. Nielsen CT, et al. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum 2012; 64: 1227-1236.
100. van Eijk IC, et al. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1378-1382.
101. Cloutier N, et al. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol Med 2013; 5: 235-249.
102. Rozmyslowicz T, et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 2003; 17: 33-42.
103. Mause SF, et al. Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 2010; 122: 495-506.
104. Risitano A, et al. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 2012; 119: 6288-6295.
105. Diehl P, et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012; 93: 633-644.
106. Laffont B, et al. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 2013; 122: 253-261.
107. Barry OP, et al. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136-144.
108. Vasina EM, et al. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis 2011; 2: e211.
109. Rautou PE, et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res 2011; 108: 335-343.
110. Sadallah S, et al. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol 2011; 186: 6543-6552.
111. Vasina EM, et al. Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release. Am J Blood Res 2013; 3: 107-123.
112. Faure V, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006; 4: 566-573.
113. Vion AC, et al. Shear stress regulates endothelial microparticle release. Circ Res 2013; 112: 1323-1333.
114. Zernecke A, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 2: ra81.
115. Abid Hussein MN, et al. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb Res 2008; 121: 865-871.
116. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011; 31: 27-33.
117. Abid Hussein MN, et al. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 2007; 98: 1096-1107.
118. Mezentsev A, et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005; 289: H1106-1114.
119. Leroyer AS, et al. Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation 2009; 119: 2808-2817.
120. Habersberger J, et al. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. Cardiovasc Res 2012; 96: 64-72.
121. Wang JG, et al. Monocytic microparticles activate endothelial cells in an IL- 1beta-dependent manner. Blood 2011; 118: 2366-2374.
122. Mallat Z, et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-353.
123. Leroyer AS, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007; 49: 772-777.
124. Kapustin AN, et al. Vascular Smooth Muscle Cell Calcification is Mediated by Regulated Exosome Secretion. Circ Res 2015; 116: 1312-1323.